Literature DB >> 22888524

MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.

Xiaoyan Yang1, Jia Yu, Jie Yin, Qiong Xiang, Huifang Tang, Xiaoyong Lei.   

Abstract

Recently, we have reported tissue- and stage-specific expression of miR-195 in human hepatocellular carcinoma cells and so far, not many reports discuss the function of this microRNA (miRNA). Expression profiling of miRNAs revealed a limited set of miRNAs with altered expression in drug resistant hepatocellular carcinoma cell line BEL-7402/5-FU compared to its parental BEL-7402 cell line. Real-time PCR confirmed down-regulation of miR-195 in BEL-7402/5-FU cells. Western blots were performed to determine protein levels of LATS2, P53 and CDK2. MTT analysed the cell proliferation activity. Flow cytometry were performed to determine apoptosis rate. Up-regulation of miR-195 increased expression of LATS2 and increased apoptosis of HCC cells, while Anti-miR-195 treatment inhibited expression of LATS2. miR-195 over-expression inhibited the luciferase activity of a LATS2 3' untranslated region-based reporter construct in BEL-7402/5-FU cells. These results indicate that miR-195 could increase cell apoptosis by targeting LATS2 in hepatocellular carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22888524

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  31 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 2.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  MicroRNA-103 promotes tumor growth and metastasis in colorectal cancer by directly targeting LATS2.

Authors:  Yong-Bin Zheng; Kuang Xiao; Gao-Chun Xiao; Shi-Lun Tong; Yu Ding; Qiu-Shuang Wang; Sheng-Bo Li; Zhi-Nan Hao
Journal:  Oncol Lett       Date:  2016-07-05       Impact factor: 2.967

4.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

6.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

7.  The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Cell Prolif       Date:  2017-03-01       Impact factor: 6.831

8.  Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.

Authors:  Shanshan Zhang; Jingxiao Wang; Haichuan Wang; Lingling Fan; Biao Fan; Billy Zeng; Junyan Tao; Xiaolei Li; Li Che; Antonio Cigliano; Silvia Ribback; Frank Dombrowski; Bin Chen; Wenming Cong; Lixin Wei; Diego F Calvisi; Xin Chen
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

9.  MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells.

Authors:  Hong-Lei Jiang; Hao Yu; Xu Ma; Dong Xu; Guo-Fu Lin; Dong-Yan Ma; Jun-Zhe Jin
Journal:  Tumour Biol       Date:  2014-04-17

10.  A novel DSN-based fluorescence assay for MicroRNA-133a detection and its application for LVH diagnosis in maintenance hemodialysis patients.

Authors:  Pei Huang; Xuedan Guo; Yan Jin; Qing Huang
Journal:  J Clin Lab Anal       Date:  2020-07-16       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.